LXEO
Lexeo Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-29
Latest data update time: Updated on 2026-03-29
7.78 / 10Overall Score
OutperformInvestment Rating
7.78 / 10Overall Score
OutperformInvestment Rating
Trend Analysis of LXEO
- Based on a composite score of 7.78/10, we rate LXEO as a Outperform. Our analysis breaks down into 3.84/10 for Fundamentals, 3.70/10 for Technicals, and 11.79/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of LXEO?
Is LXEO undervalued or overvalued?
Is money flowing into or out of LXEO?
Trend Analysis of LXEO
- Based on a composite score of 7.78/10, we rate LXEO as a Outperform. Our analysis breaks down into 3.84/10 for Fundamentals, 3.70/10 for Technicals, and 11.79/10 for Sentiment, indicating the stock is likely to See further upside.
Is LXEO undervalued or overvalued?
Technical Analysis of LXEO?
Is money flowing into or out of LXEO?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
